A 30-year-old Indonesian student became the first Influenza A(H1N1) related fatality in Malaysia, although the cause of death was not the disease itself.
The student, from the International Centre for Education in Islamic Finance in Kuala Lumpur, died from cardiac arrest due to ventricular fibrillation, Health Minister Datuk Seri Liow Tiong Lai said on today. - (The Star online)
...And a vaccine soon ...
Australia has begun its world-first human trials of a vaccine for this deadly flu.
According to the Australian Associated Press (AAP), Australian bio-pharmaceutical company CSL, the makers of the vaccine, believe it will protect against the H1N1 virus.
Yesterday, some 240 adults were injected with the vaccine at the Royal Adelaide Hospital in trials.
A further trial of the vaccine on 400 children will begin on August 4.
So far, Australia recorded more than 40 deaths.
Quoting CSL's research and development director Andrew Cuthbertson, AAP reported that said the vaccine should be proven by late September.
The (Australian) federal government has already ordered 21 million doses of the vaccine.
"As soon as I have confirmation that the vaccine is safe and effective, I will ensure it can be rolled out to the community," federal Health Minister Nicola Roxon said yesterday.
The adult trials, to take six weeks to complete, are testing the appropriate dose of the vaccine.